Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proto Labs (PRLB) EBT (2016 - 2025)

Historic EBT for Proto Labs (PRLB) over the last 14 years, with Q3 2025 value amounting to $10.3 million.

  • Proto Labs' EBT rose 388.12% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year decrease of 3514.85%. This contributed to the annual value of $24.7 million for FY2024, which is 1173.44% down from last year.
  • According to the latest figures from Q3 2025, Proto Labs' EBT is $10.3 million, which was up 388.12% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Proto Labs' EBT ranged from a high of $16.2 million in Q2 2021 and a low of -$116.7 million during Q4 2022
  • Over the past 5 years, Proto Labs' median EBT value was $7.1 million (recorded in 2021), while the average stood at $939000.0.
  • As far as peak fluctuations go, Proto Labs' EBT tumbled by 100243.58% in 2022, and later surged by 22857.14% in 2024.
  • Proto Labs' EBT (Quarter) stood at $12.9 million in 2021, then crashed by 1002.44% to -$116.7 million in 2022, then soared by 108.52% to $9.9 million in 2023, then crashed by 102.84% to -$282000.0 in 2024, then surged by 3735.11% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $6.7 million for Q2 2025, and $6.0 million during Q1 2025.